Immunohistochemical Analysis of ALK Fusion-Positive Lung Cancers: Correlation with FISH, Molecular Findings and Morphology

被引：0
|
作者：
Saab, S. T.
Lovly, C.
Hollis, C. J.
Ashwini, Y.
Ji, H.
Pao, W.
Gonzalez, A.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Chinese Acad Sci, Shanghai, Peoples R China
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1799
引用
收藏
页码：423A / 423A
页数：1
相关论文
共 50 条
  • [1] Immunohistochemical Analysis of ALK Fusion-Positive Lung Cancers: Correlation with FISH, Molecular Findings and Morphology
    Saab, S. T.
    Lovly, C.
    Hollis, C. J.
    Ashwini, Y.
    Ji, H.
    Pao, W.
    Gonzalez, A.
    LABORATORY INVESTIGATION, 2011, 91 : 423A - 423A
  • [2] Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Drilon, Alexander E.
    Hellmann, Matthew David
    Wang, Lu
    Cho, Eun Jung
    Ladanyi, Marc
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series
    Ambrosini, Margherita
    Del Re, Marzia
    Manca, Paolo
    Hendifar, Andrew
    Drilon, Alexander
    Harada, Guilherme
    Ree, Anne Hansen
    Klempner, Samuel
    Maelandsmo, Gunhild Mari
    Flatmark, Kjersti
    Russnes, Hege G.
    Cleary, James M.
    Singh, Harshabad
    Sottotetti, Elisa
    Martinetti, Antonia
    Randon, Giovanni
    Sartore-Bianchi, Andrea
    Capone, Iolanda
    Milione, Massimo
    Di Bartolomeo, Maria
    Pietrantonio, Filippo
    JCO PRECISION ONCOLOGY, 2022, 6 (01)
  • [4] Brain Metastases in Patients with Fusion-Positive Lung Cancers
    Sui, J. S.
    Chen, M. F.
    Wilcox, J.
    Yang, S. R.
    Li, B. T.
    Riely, G. J.
    Offin, M.
    Yu, H. A.
    Kris, M. G.
    Drilon, A. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S354 - S354
  • [5] RET FUSION-POSITIVE ADVANCED LUNG CANCERS: RESPONSE TO FIRST-LINE CHEMOTHERAPY AND SURVIVAL IN COMPARISON TO ROS1 AND ALK FUSION-POSITIVE AND EGFR- AND KRAS-MUTANT LUNG CANCERS
    Drilon, Alexander
    Wang, Lu
    Joubert, Philippe
    Snyder, Alexandra
    Cho, Eun Jung
    Riely, Gregory
    Kris, Mark
    Ladanyi, Marc
    Rizvi, Naiyer
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S902 - S903
  • [6] Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT
    Nakada, Takeo
    Okumura, Sakae
    Kuroda, Hiroaki
    Uehara, Hirofumi
    Mun, Mingyon
    Takeuchi, Kengo
    Nakagawa, Ken
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 21 (02) : 102 - 108
  • [7] Frequency and Outcomes of Leptomeningeal Metastases in Patients with Fusion-Positive Lung Cancers
    Chen, M.
    Sui, J.
    Wilcox, J.
    Yang, S. R.
    Imber, B.
    Offin, M.
    Yu, H.
    Kris, M. G.
    Drilon, A. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S677 - S677
  • [8] Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients
    Xia, Wenchao
    Yang, Jing
    Li, Hongbin
    Li, Ling
    Liu, Jinfeng
    GLOBAL MEDICAL GENETICS, 2024, 11 (02): : 175 - 186
  • [9] Correlation of Cytomorphology and Molecular Findings in EGFR, KRAS, and ALK-Positive Lung Carcinomas
    Li, Z.
    Dacic, S.
    Pantanowitz, L.
    Khalbuss, W.
    Nikiforova, M.
    Monaco, S. E.
    LABORATORY INVESTIGATION, 2013, 93 : 458A - 458A
  • [10] Correlation of Cytomorphology and Molecular Findings in EGFR, KRAS, and ALK-Positive Lung Carcinomas
    Li, Z.
    Dacic, S.
    Pantanowitz, L.
    Khalbuss, W.
    Nikiforova, M.
    Monaco, S. E.
    MODERN PATHOLOGY, 2013, 26 : 458A - 458A
12345